Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 27.80M | £ 19.00M | £ 44.10M | £ 37.70M | £ 31.20M |
Total Assets | £ 541.50M | £ 491.70M | £ 540.80M | £ 512.20M | £ 571.50M |
Total Debt | £ 252.80M | £ 238.80M | £ 282.60M | £ 269.60M | £ 296.90M |
Net Debt | £ 225.00M | £ 219.80M | £ 238.50M | £ 231.90M | £ 265.70M |
Total Liabilities | £ 455.30M | £ 387.80M | £ 448.80M | £ 421.80M | £ 468.80M |
Stockholders Equity | £ 86.20M | £ 103.90M | £ 92.00M | £ 90.40M | £ 102.70M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |